Quality Systems

Patricia Van Arnum was executive editor of Pharmaceutical Technology.

Articles

Pharmaceutical Technology's annual survey on equipment and machinery reveals the spending levels and type of spending made in 2010 and planned for 2011.

Measuring Spending Levels

Stephanie Sutton was an assistant editor at Pharmaceutical Technology Europe.

The EU Commission is on the lookout for "potentially problematic patent settlements" and has asked several pharma companies to submit copies of their patent settlement agreements made between originator and generic companies.

EU Examines Patent Settlements

Iain Moore explains what progress has been made so far regarding EU plans to regulate excipients.

An Update On The EU's Plans For Excipient Regulation

Excipients should be regulated to manage risk. Although, excipients are an integral part of a finished pharmaceutical product, the issue of regulation is complex.

Is There A Need For Stringent Regulations For Excipients?

Holding product and supply-chain security to the highest standards is crucial for the future.

The US Drug Supply Chain: Safety Must be Paramount

Angie Drakulich was editorial director of Pharmaceutical Technology.

The European Medicines Agency launched on December 20, 2010, a public registry about small and medium-sized enterprises (SME) that includes information about SME-registered companies.

EMA Opens Registry for Small and Medium Companies

The International Conference on Harmonization (ICH) Steering Committee (SC) and its working groups met in Fukuoka, Japan Nov. 6-11, 2010.

ICH Meets in Japan

The European Medicines Agency (EMA) has adopted new policies on access to documents and the handling of conflicts of interest

EMA Adopts New Document-Access Policy

GlaxoSmithKline Consumer Healthcare, Cephalon UK Ltd, and ProStraken Group plc have been accused of breaching the Association of the British Pharmaceutical Industry's (ABPI) Code of Practice.

GSK Breaches ABPI Code of Conduct

Legislative efforts to modernize provisions in the Toxic Substances Control Act of 1976 (TSCA), which involve chemical safety and reporting requirements is drawing criticism from the chemical industry.

Quality by Design